Vator Splash San Francisco

From the event registration site: “The Splash event, hosted by Vator, is a single-track evening event and startup competition. Splash gathers leading entrepreneurs, innovators and financiers across technology to inspire and energize the audience about entrepreneurship and innovation. Splash brings together high-caliber speakers who talk about how to build and scale great successful companies, how … Continue reading “Vator Splash San Francisco”

Bruce Montgomery’s New Startup, Cardeas Pharma, Raises $5M

Bruce Montgomery, the prominent Seattle biotech entrepreneur, has raised $5 million for his latest startup, Xconomy has learned. Cardeas Pharma has pulled in $5 million in equity financing, in the first of two planned closings, Montgomery said in an e-mail. The syndicate is being led by Novo Ventures, and includes San Diego-based Avalon Ventures, Seattle-based … Continue reading “Bruce Montgomery’s New Startup, Cardeas Pharma, Raises $5M”

Under Generic Pressure, San Diego’s Somaxon Looks for New Options

Business hasn’t gotten any easier over the past six months for San Diego’s Somaxon Pharmaceuticals (NASDAQ: [[ticker:SOMX]]), which says it has hired the investment banking firm Stifel Nicolaus Weisel to help the company assess its strategic options. The company also laid off 60 percent of its employees who aren’t out in the field. The company … Continue reading “Under Generic Pressure, San Diego’s Somaxon Looks for New Options”

Could RockMelt Become the New Third Party in the Browser Campaigns?

The United States seems stuck with a two-party political system. We don’t always have the same two parties—the Whigs were replaced by the Republicans in the 1850s, for example—but there doesn’t seem to be space in the American psyche for a third major player to take root. Could something similar be true of the Web … Continue reading “Could RockMelt Become the New Third Party in the Browser Campaigns?”

In Search of Next Killer App, SweetLabs Partners with Kabam on Games

SweetLabs co-founder Chester Ng tells me a new class of intense social network games are threatening to disrupt some of the established players in the desktop gaming business, such as Activision Blizzard’s World of Warcraft and Electronic Arts’ Star Wars franchise. Perhaps. Today, as EA releases its much-anticipated Star Wars: The Old Republic, San Diego-based … Continue reading “In Search of Next Killer App, SweetLabs Partners with Kabam on Games”

After Years of Legal Battles, Vlingo to Be Acquired by Nuance

Cambridge, MA-based voice-to-text tech startup Vlingo, which just three months ago charged Nuance Communications with unfair competition, commercial bribery, breach of contract, and intentional interference with prospective business relationships, is being acquired by the Burlington, MA-based speech software giant, according to an announcement today. Nuance (NASDAQ: [[ticker:NUAN]]) and Vlingo, which develops speech-recognition technology for cell … Continue reading “After Years of Legal Battles, Vlingo to Be Acquired by Nuance”

Appssavvy, Backed by AOL Ventures, Raises $7.1M in Series 1-A Round

Advertising technology company appssavvy in New York said in a press release issued Tuesday it raised $7.1 million in a Series 1-A round that included new investor AOL Ventures as well as current investors. Three-year-old appssavvy developed an activity-based advertising platform called adtivity. In 2010, the company raised $3.1 million in a round that included … Continue reading “Appssavvy, Backed by AOL Ventures, Raises $7.1M in Series 1-A Round”

Excelimmune Adds $12M to Advance Polyclonal Antibodies

Woburn, MA-based Excelimmune announced today that it has raised $12 million from an undisclosed “private” investor. The funding follows close on the heels of a $10.5 million Series B round the company announced in May. Excelimmune is developing “polyclonal” antibodies, which are therapeutic proteins designed to bind to multiple regions of specific disease-causing antigens. The … Continue reading “Excelimmune Adds $12M to Advance Polyclonal Antibodies”

MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs

Geneticist Arthur Tinkelenberg has always been struck by the lack of strategy in scientific research. “Historically it’s been somewhat ad hoc,” he says. “For example, why do we study fruit flies? Because somewhere in the dim past, somebody did something interesting with a fruit fly, and now you have a whole field.” So when Tinkelenberg … Continue reading “MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs”

The Genetics Institute Impact: Caught on Video

We don’t always capture Xconomy events on video, but fortunately the camera was rolling last week at our biggest Boston biotech event of the year—“The Genetics Institute Impact.“ For those of you who missed it, this was the event that brought together more than 250 people from one of Boston’s pioneering biotech companies from the … Continue reading “The Genetics Institute Impact: Caught on Video”

Boston: Cradle of Liberty and Data Startups

I didn’t know the full extent to which the Boston area has a thriving data and analytics startup scene. I had always associated the city primarily with biotech innovation. My company, Chart.io, provides hosted business dashboards to help companies visualize their database data. We’re based out in San Francisco (we were part of the 2010 … Continue reading “Boston: Cradle of Liberty and Data Startups”

A123 Systems, NSTAR Partner on Grid Energy Storage Project

Waltham, MA-headquartered lithium-ion battery manufacturer A123 Systems, which has operations in Michigan, announced today that it is kicking off a pilot project with Boston-based NSTAR to study the benefits of employing the A123’s grid battery technology in a suburban electric grid. The system, NSTAR’s first battery energy storage project, is expected to be up and running in 2012 … Continue reading “A123 Systems, NSTAR Partner on Grid Energy Storage Project”

Skyword Garners $6,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d90612c1-ebe1-4a53-aaa3-00a899564a0b&Preview=1 Date 12/20/2011 Company Name Skyword Mailing Address 234 Congress St. fourth floor Boston, MA 02110 Company Description Skyword is the leader in Search-Driven Media (SDM). Skyword enables brands to acquire and engage customers through efficient forecasting, creation and placement of brand-aligned content that precisely matches consumer search. Clients include Proctor & … Continue reading “Skyword Garners $6,000,000 New Round”

Matchbox Secures $2,500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d6d94957-e357-44ee-954c-86993ba86350&Preview=1 Date 12/20/2011 Company Name Matchbox Mailing Address One Broadway 14th Floor Cambridge, MA 02142 Company Description Matchbox helps universities accelerate and improve their entire recruitment process. Website http://www.matchbox.net Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Floodgate Venture … Continue reading “Matchbox Secures $2,500,000 New Financing”

Excelimmune Lands $12,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0e472db2-b67c-4e71-b2b5-8fe433a3f362&Preview=1 Date 12/20/2011 Company Name Excelimmune Mailing Address 12-B Cabot Road Woburn, MA 01801 Company Description Excelimmune Inc., based in Cambridge, is a biotechnology company developing therapuetic applications of human recombinant polyclonal antibodies. Website http://www.excelimmune.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction Round Undisclosed Proceeds Purposes Novel treatments in nocosomial infections … Continue reading “Excelimmune Lands $12,000,000 New Round”

Nuance Communications Acquires Vlingo for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f9396b9-3b9a-4c3f-8743-cef5fbd4d0fe&Preview=1 Date 12/20/2011 Company Name Vlingo Mailing Address 17 Dunster Street Cambridge, MA 02138 Company Description At vlingo we unlock access to wireless data services. We provide wireless carriers and wireless application providers a voice interface to their applications. With vlingo, instead of triple-tapping on a small keyboard, users can now simply … Continue reading “Nuance Communications Acquires Vlingo for Undisclosed Sum”

Quarterly Lands Seed Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=185857a4-0084-4d22-b155-47eda1a2b0ca&Preview=1 Date 12/20/2011 Company Name Quarterly Mailing Address P.O. Box 69307 West Hollywood, CA 90069 Company Description Quarterly is a new way to connect with the people you follow and find interesting. We spend so much of our lives connecting with people online that we forget the value of tangible interactions that … Continue reading “Quarterly Lands Seed Funding”

ReVision Therapeutics Obtains $500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5f2e0401-46ec-49db-a991-e5a7b51846c5&Preview=1 Date 12/20/2011 Company Name ReVision Therapeutics Mailing Address 5626 Oberlin Drive San Diego, CA 92121 Company Description ReVision Therapeutics is focused on developing fenretinide for the treatment of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. There are currently no treatments for the dry form of AMD, … Continue reading “ReVision Therapeutics Obtains $500,000 New Financing”

Tangoe Acquires ProfitLine for $23,500,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a59e17fe-617c-4493-9608-d3ab162340ca&Preview=1 Date 12/20/2011 Company Name ProfitLine Mailing Address 9920 Pacific Heights Blvd. San Diego, CA 92121 Company Description ProfitLine is the premier provider of telecom expense management services for Fortune 1000 companies. The company’s outsourced solution streamlines and manages the entire telecom lifecycle process for both wireline and wireless. Website http://www.profitline.com Transaction … Continue reading “Tangoe Acquires ProfitLine for $23,500,000”

EnVerv Receives $12,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b934753a-f384-465f-a2b1-0332756d13fb&Preview=1 Date 12/20/2011 Company Name EnVerv Mailing Address 680 N McCarthy Blvd San Jose, CA 95035 Company Description EnVerv’s vision is to provide power line communications solutions to smart meters toward ubiquitous Smart Grid Networks. We believe that every node in the network needs to be connected reliably and with enough robust … Continue reading “EnVerv Receives $12,000,000 Series B Round”

Keas Garners $6,500,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=00af6cae-90cc-45a3-9fff-2ad2e250c583&Preview=1 Date 12/20/2011 Company Name Keas Mailing Address 585 Howard St Second Floor San Francisco , CA 94105 Company Description The company operates an online personal health platform. Website http://www.keas.com Transaction Type Venture Equity Transaction Amount $6,500,000 Transaction Round Series B Proceeds Purposes Keas will use the new financing to support continued … Continue reading “Keas Garners $6,500,000 Series B Financing Round”

PharmacoFore Receives $10,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54c6fcb8-153c-418f-927d-765e63c8275c&Preview=1 Date 12/20/2011 Company Name PharmacoFore Mailing Address 75 Shoreway Rd San Carlos, CA 94070 Company Description PharmacoFore is a privately-held biopharmaceutical company focused on creating novel medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications. Website http://www.pharmacofore.com … Continue reading “PharmacoFore Receives $10,000,000 New Funding”

Marseille Networks Secures $9,999,999 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed68769b-de1a-4ef7-9dc6-a4f7e12e4006&Preview=1 Date 12/20/2011 Company Name Marseille Networks Mailing Address 3211 Scott Blvd. Santa Clara, CA 95054 Company Description As the leader of a new wave of fabless semiconductor companies and creator of chip virtualization and Quad-HD video processing technology, Marseille has pioneered a method allowing it to bring new chips to market … Continue reading “Marseille Networks Secures $9,999,999 New Round”

Houzz Lands $11,600,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5ea54a4d-bc33-4882-bbcc-b9994aa8d2b3&Preview=1 Date 12/20/2011 Company Name Houzz Mailing Address Undisclosed Palo Alto, CA 94301 Company Description Houzz is a community and photo database for home design enthusiasts, with the largest collection of high quality home design photos available online. Website http://www.houzz.com Transaction Type Venture Equity Transaction Amount $11,600,000 Transaction Round Series B Proceeds … Continue reading “Houzz Lands $11,600,000 Series B Funding”

Aviir Obtains $30,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c0cd07f3-76ed-4091-9dd7-caf3bdf5dbe2&Preview=1 Date 12/20/2011 Company Name Aviir Mailing Address 2463 Faber Place Palo Alto, CA 94303 Company Description Aviir is a venture-funded biotechnology company developing cutting-edge, convenient diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology draws on years of research at Stanford University, and combines the scientific … Continue reading “Aviir Obtains $30,000,000 New Round”

Crown Castle Acquires NextG Networks for $1,000,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=84700811-57b2-469a-b51f-3aee48562c31&Preview=1 Date 12/20/2011 Company Name NextG Networks Mailing Address 2216 O’Toole Ave San Jose, CA 95131 Company Description NextG Networks is a next-generation wireless communications company that provides managed RF-over-Fiber transport network services to wireless service providers. Website http://www.nextgnetworks.net Transaction Type M&A Transaction Amount $1,000,000,000 Transaction Round Proceeds Purposes M&A Terms Crown … Continue reading “Crown Castle Acquires NextG Networks for $1,000,000,000”

Cardeas Pharma Obtains $5,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8e14fea4-bd41-4899-be4c-786be0d56406&Preview=1 Date 12/20/2011 Company Name Cardeas Pharma Mailing Address 2518 Eastlake Ave. E. Seattle, WA 98102 Company Description The company is a stealth mode pharmaceutical developer. Website Undisclosed Transaction Type Venture Equity Transaction Amount $5,000,000 Transaction Round Undisclosed Proceeds Purposes The company plans to use the money to run both preclinical experiments … Continue reading “Cardeas Pharma Obtains $5,000,000 New Funding Round”

C.R. Bard Acquires Lutonix for $325,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3800a904-2604-4aa4-9622-dc8d1106a13c&Preview=1 Date 12/20/2011 Company Name Lutonix Mailing Address 7351 Kirkwood Lane North Maple Grove, MN 55369 Company Description The Vision of Lutonix is to improve the quality of life for patients with vascular disease through innovative solutions. The Mission of Lutonix is to rapidly develop and commercialize the safest and most efficacious … Continue reading “C.R. Bard Acquires Lutonix for $325,000,000”

eRecyclingCorps Lands $35,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94bf7817-eb2e-4c51-82ef-2eb23051da23&Preview=1 Date 12/20/2011 Company Name eRecyclingCorps Mailing Address 909 Hidden Ridge Irving, TX 75038 Company Description The company buys, recycles, and resells used cell phones. Website http://www.erecyclingcorps.com Transaction Type Venture Equity Transaction Amount $35,000,000 Transaction Round Undisclosed Proceeds Purposes As eRecyclingCorps expands to reach more carriers and retailers around the world, Kleiner … Continue reading “eRecyclingCorps Lands $35,000,000 New Funding Round”

Appconomy Secures $10,000,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1d98750b-b37c-4386-894b-7cbc0673b9ec&Preview=1 Date 12/20/2011 Company Name Appconomy Mailing Address 1300 Guadalupe St Austin, TX 78701 Company Description Appconomy designs, develops and sells mobile apps and app components, and AppCommerce capabilities that power the economies of people, businesses and enterprises. Website http://www.appconomy.com Transaction Type Venture Equity Transaction Amount $10,000,000 Transaction Round Series A Proceeds … Continue reading “Appconomy Secures $10,000,000 Series A Funding”

Realizing Value from Innovation: Successful Business Models for New Technologies

Connect has arranged with Agile Strategy to lead this workshop, which is intended to cover the essentials of designing a successful business model for technology innovation. The class covers the purpose and key elements of a business model, optimizing the business model to maximize total value, evaluating the model across the life cycle of innovation, … Continue reading “Realizing Value from Innovation: Successful Business Models for New Technologies”

Tafamidis: The First Drug Approved for a Rare Neurodegenerative Disease

Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) is a rare, progressive and fatal neurodegenerative disease that affects approximately 8,000 patients worldwide. Based on results from a pivotal 18-month placebo controlled clinical trial featuring an 18-month follow-on study, Pfizer’s tafamidis (Vyndaqel) has proven its effectiveness in delaying peripheral neurologic impairment. In giving the drug its green light, the … Continue reading “Tafamidis: The First Drug Approved for a Rare Neurodegenerative Disease”

What Now? Reactions, Questions After the AT&T-Mo Failure

There’s got to be plenty of mixed feelings for all those magenta-clad T-Mobile folks in Bellevue right now. News that AT&T is abandoning its mega-merger attempt to acquire the fourth-place U.S. wireless carrier raises a ton of questions about T-Mobile’s future—none of them particularly reassuring. Now that AT&T is on the hook for a $4 … Continue reading “What Now? Reactions, Questions After the AT&T-Mo Failure”

MIT Enterprise Forum: Artificial intelligence and ai one

Unlike other forms of artificial intelligence, San Diego-based ai-one’s biologically inspired technology learns without human intervention, requires less than a day of training to use, and works with existing standards and programming languages. The challenge for ai one lies in creating awareness of this latest advance in artificial intelligence. Networking and registration at the door … Continue reading “MIT Enterprise Forum: Artificial intelligence and ai one”

Science and Medical Literacy and Underserved Populations

In the fifth of nine presentations inspired by the book, The Immortal Life of Henrietta Lacks, Tate Hurvitz of Grossmont College talks about the difficult personal and institutional challenges of introducing ways of teaching science literacy, with strategies for decoding challenging information and assessing the credibility and validity of scientific sources. More information and online … Continue reading “Science and Medical Literacy and Underserved Populations”

CalBio2012 in San Francisco

CalBio2012 is a statewide conference produced by Biocom, San Diego’s nonprofit life sciences industry group, and BayBio, it’s counterpart in San Francisco. The 2011 conference had almost 1,000 registered participants from 14 countries, 23 states, and 163 life sciences companies. This year more than 1,500 are expected, with heavy attendance from San Diego’s life sciences … Continue reading “CalBio2012 in San Francisco”

Tech Roundup of the Week: Ford Focus EV, Flud, Legend3D, Sotera

—Quest Software (NASDAQ: [[ticker:QSFT]]), the IT software provider on the border between San Diego and Orange Counties, said today it acquired BitKOO, a North Hollywood, CA-based specialist in identity and access management technology. Financial terms were not disclosed. Combined with the recent acquisitions of e-DMZ (privileged identity management), Völcker Informatik AG (provisioning), and Symlabs (virtual … Continue reading “Tech Roundup of the Week: Ford Focus EV, Flud, Legend3D, Sotera”

AT&T Drops T-Mobile Bid, Will Pay $4B Breakup Fee

After a brutal few months battling Obama administration officials on two fronts, AT&T has given up its blockbuster $39 billion bid to acquire Bellevue, WA-based T-Mobile USA from Deutsche Telekom. The end of an outright merger was clearly telegraphed a week ago, when the two companies and the Justice Department postponed a federal antitrust lawsuit. … Continue reading “AT&T Drops T-Mobile Bid, Will Pay $4B Breakup Fee”

Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs

Amgen has spent years defending itself from enemies in the generic drug business, but now the world’s largest biotech company has found a way to join forces with a major maker of copycat pharmaceuticals. Thousand Oaks, CA-based Amgen (NASDAQ: [[ticker:AMGN]]), which has R&D operations in Seattle, San Francisco, and Boston, said today it has agreed to … Continue reading “Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs”

Skyword Scores $6M to Blend Media and Marketing

Boston-based Skyword is moving up in the world. The startup, which makes a software platform for brands to create Web content, said today it has closed $6 million in financing from Cox Media Group. The company says it helps publishers—which is marketing-speak for retail and industry brands, as well as media companies—create online content “for … Continue reading “Skyword Scores $6M to Blend Media and Marketing”

Metamark Inks Potential $365M Deal with J&J For Cancer Marker Discovery

Cambridge, MA-based Metamark Genetics said today it had entered into a research agreement with Janssen Biotech, a unit of New Brunswick, NJ-based Johnson & Johnson (NYSE: [[ticker:JNJ]]). Metamark, which was founded in 2007 on science from the Dana-Farber Cancer Institute, is developing prognostic tests based on genes discovered to play a role in how tumors progress and … Continue reading “Metamark Inks Potential $365M Deal with J&J For Cancer Marker Discovery”

Health Care Reform Is Coming To Town

Last year about this time of year I wrote a parody of ‘Twas the Night Before Christmas about the coming of healthcare IT and meaningful use. I decided to make these holiday parody songs an annual event. I figure I have years of material, as there are so many ways of ruining an otherwise joyous … Continue reading “Health Care Reform Is Coming To Town”

EnVerv Raises $12 Million to Advance Power Line Communications Chips

EnVerv, a chip design firm based in San Jose, CA, says this morning it has raised $12 million in a Series B round for its “system-on-a-chip” technology, which enables a utility to use its own power lines to serve as a smart grid communications network. Benchmark Capital led the new round, which was joined by … Continue reading “EnVerv Raises $12 Million to Advance Power Line Communications Chips”

Zynga, Twitter, NextG: Bay Area BizTech by the Numbers

Time for our roundup of the latest deals news from Bay Area technology companies, from biggest to smallest. And today’s biggest numbers are pretty big. $1 billion—The approximate amount raised by social game maker Zynga (NASDAQ: [[ticker:ZNGA]]) in its IPO last Thursday. The company’s shares priced at $10 per share, momentarily giving it a market … Continue reading “Zynga, Twitter, NextG: Bay Area BizTech by the Numbers”

MediaBrix Raises $4M with Edison Ventures, Plans to Grow Staff in 2012

MediaBrix, a New York-based developer of a social media advertising platform, closed a $4 million Series B funding round. MediaBrix CEO Ari Brandt says Edison Ventures was the sole investor in the round. Edison Ventures principal Ryan Ziegler, and Mike Leo, CEO of the advertising software maker Operative in New York, joined MediaBrix’s board in … Continue reading “MediaBrix Raises $4M with Edison Ventures, Plans to Grow Staff in 2012”

Trius Antibiotic Passes Pivotal Study Against Pfizer’s Zyvox

San Diego-based Trius Therapeutics (NASDAQ: [[ticker:TSRX]]) got some long-awaited good news today for its lead antibiotic in development. The company said today that its experimental drug, tedizolid phosphate, met the main goal of its pivotal clinical trial by showing it was roughly equal (non-inferior) to Pfizer’s linezolid (Zyvox) when treating acute skin and skin structure … Continue reading “Trius Antibiotic Passes Pivotal Study Against Pfizer’s Zyvox”

Burrill Raises $313M for New Life Sciences Fund

San Francisco-based biotech industry maven Steve Burrill said today his investment firm has raised $313 million for a new life sciences fund. The Burrill Capital Fund IV started operations on December 1 with $313 million to make a wide variety of early and late-stage investments in companies working on drugs, diagnostics, and medical devices, as … Continue reading “Burrill Raises $313M for New Life Sciences Fund”

Biofuels Firm Coskata, Backed by Boston VCs, Files for IPO

Here’s another data point for New England cleantech investors. Coskata, a Warrenville, IL-based developer of cellulosic ethanol, has filed paperwork for an initial public offering. The proposed maximum offering is $100 million, but as usual, that doesn’t mean much at this point. Coskata is backed by a couple of Boston-area venture firms—Advanced Technology Ventures and … Continue reading “Biofuels Firm Coskata, Backed by Boston VCs, Files for IPO”

Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward

The path to becoming a publicly listed company chosen by Coronado Biosciences (NASDAQ: [[ticker:CNDO]]) was anything but conventional, but it seems to be working for the biotech startup. After raising $47.4 million privately over the last year, the company filed a Form 10 with the SEC so it could become a public company by registering all … Continue reading “Coronado Biosciences Debuts on Nasdaq, Moves Two Lead Drugs Forward”